Skip to content

Sharp offer well-established QP services, helping to streamline your product’s journey to trial and market in the EU and giving you and your customers confidence that your products have been manufactured to the very highest standards.

QP Release Services

Once a satisfactory audit is complete, your Sharp QP will issue a declaration that you can use to submit your Clinical Trial Authorisation (CTA). We can then work with you to manage the storage and distribution of your clinical trial supplies to your testing sites.

The Role of a (QP) Qualified Person

It is a requirement within the EU that all investigational and medicinal products manufactured or imported by organisations holding a MA IMP, have a QP to approve and release each batch of IMP for usage in clinical trials. QPs have gained personal knowledge of the quality systems used at the manufacturing site, usually through an EU Good Manufacturing Practice Audit.

QPs are assigned projects according to their specialist expertise and have personal and legal responsibility as defined by the EU Clinical Trial Directive (2001/20/EC).

Talk to our expert team today about your QP release needs.

Related Resources

Today we celebrate the life and achievements of Dr. Martin Luther King Jr., influential American civil rights leader whose work to promote equal rights, regardless of background, changed history. #MLKDay

One size does not fit all. This is why Sharp has developed a suite of flexible, scalable and efficient clinical trial management solutions including Clinteract IRT and Clinventory IMS.

Contact us today to schedule a demo: https://lnkd.in/ekUQmFH

#clinicalIRT

Sharp’s analytical chemists offer a variety of photostability studies for your drug substance or product.

Contact us today to discover how our specialist solutions can improve your #clinicaltrial processes: https://www.sharpservices.com/our-services/clinical/

#drugdevelopment #clinicalservices